K. I offer these suggestions for questions.
1. What was the source of the sol, and the method of production? 2. Was the sol tested for mg/L [PPM]? 3. Has the sol been examined for particle size? 4. If so, what was the observed concentration and/or particle size? 5. Were any other therapies being used concurrently with the Ag sol? 6. Did the patients have any history or suspected history of Amyl Nitrate use? 7. Any history of IV non-prescription drug use? 8. Has the argyria been confirmed by clinical diagnosis other than gross examination? 9. What secondary conditions did the patients have as a result of compromised immune system? Thanks. James Osbourne Holmes [email protected] -----Original Message----- From: Katarina Wittich [SMTP:[email protected]] Sent: Tuesday, December 14, 1999 5:58 PM To: [email protected] Subject: CS>Re:CS/Argyria/James Hi James, The doctor's name is Dr. Hans Gruen, here in LA. It was my impression that he was talking not about studies but about direct experience that he and his colleagues have had. I have another appointment with him in January and I'll try to ask him more then. Katarina > Can we contact the doctor for the source of his data? > James Osbourne Holmes > [email protected] > -- The silver-list is a moderated forum for discussion of colloidal silver. To join or quit silver-list or silver-digest send an e-mail message to: [email protected] -or- [email protected] with the word subscribe or unsubscribe in the SUBJECT line. To post, address your message to: [email protected] Silver-list archive: http://escribe.com/health/thesilverlist/index.html List maintainer: Mike Devour <[email protected]>
